Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

Conditions: Melanoma Interventions: Drug: Defactinib; Drug: Avutometinib; Drug: Encorafenib Sponsors: University of Utah; Verastem, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials